A Study To Understand Public Knowledge And Perception Towards Immunity Food Booster's Consumption During COVID-19 Pandemic

COVID-19 pandemic has brought a significant change in the lives of all population segments. Irrespective of the country, religion, economic status, and position worldwide, a committed thought is developed on "IMMUNITY" and "IMMUNITY BOOSTERS."The nutrition and health portfolio of many populations worldwide reported severe impacts from changing trends in modern lifestyle, food habits, food consumption, and the environment. Defining health remains a crucial task over several decades. The present study is to understand and evaluate the knowledge and purchasing behaviour of the population during COVID-19 time. A survey is conducted through social media platforms with pre-designed and tested questionnaires. Data were collected from 200 respondents. A rapid assessment survey was conducted using Google Forms. Google Form was distributed through various social media platforms such as WhatsApp, Facebook, and LinkedIn in Indian communities residing across the globe. The above data shows that 64% have consumed Vitamin C supplements almost every day for 15 days, 13% for one month, 10% of the respondents more than one month, and 13% took supplements as supplements per the doctor's advice. The results indicate that nearly 73% of the respondents started consuming supplements, 15% sometimes, and 4% of the respondents expressed their consumption was on and off. When questioned in detail, it is mentioned that they have taken supplements. The results depict buying behaviours, reading and understanding the food labels, purchasing supplements and immune boostersCopyright © 2023, Research Journal of Pharmaceutical, Biological and Chemical Sciences.All Rights Reserved.

Pyrrolo[2,3-b]quinoxalines in attenuating cytokine storm in COVID-19: their sonochemical synthesis and in silico / in vitro assessment.

In view of the recent global pandemic caused by COVID-19 intense efforts have been devoted worldwide towards the development of an effective treatment for this disease. Recently, PDE4 inhibitors have been suggested to attenuate the cytokine storm in COVID-19 especially tumour necrosis factor alpha (TNF-α). In our effort we have explored the 2-substituted pyrrolo[2,3-b]quinoxalines for this purpose because of their potential inhibitory properties of PDE-4 / TNF-α. Moreover, several of these compounds appeared to be promising in silico when assessed for their binding affinities via docking into the N-terminal RNA-binding domain (NTD) of N-protein of SARS-CoV-2. A rapid and one-pot synthesis of this class of molecules was achieved via the Cu-catalyzed coupling-cyclization-desulfinylation of 3-alkynyl-2-chloroquinoxalines with t-butyl sulfinamide as the ammonia surrogate under ultrasound irradiation. Most of these compounds showed good to significant inhibition of TNF-α in vitro establishing a SAR (Structure Activity Relationship) within the series. One compound e.g. 3i was identified as a promising hit for which the desirable ADME and acceptable toxicity profile was predicted in silico.